Clinical Trials Directory

Trials / Completed

CompletedNCT00997737

Diaphragm Activity During Incentive Spirometry and Diaphragmatic Breathing

Diaphragm Mobility During Respiratory Exercises With Incentive Spirometry in Healthy Individuals

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Hospital Sirio-Libanes · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The objective of the present study is to evaluate diaphragm activity during three breathing exercises: diaphragmatic breathing (DB), flow-oriented (Triflo II)incentive spirometry and volume-oriented (Voldyne) incentive spirometry. Seventeen healthy subjects will be studied (8 man and 9 woman).

Detailed description

Right diaphragmatic mobility will be evaluated by determining the craniocaudal displacement of the left branch of the portal vein using a B-mode ultrasound device (Logic 500, Pro Series®; General ElectricMedical Systems, Milwaukee, WI, USA). The ultrasound technician will use a 3.5 MHz convex transducer positioned in the right subcostal region, with the incidence angle perpendicular to the craniocaudal axis, in the direction of the inferior vena cava. Next, an intraparenchymal portal branch will be identified in the field of vision and its position will be traced with the curser during the forced inspiration and expiration. The craniocaudal displacement of these points will be considered to be the amount of right diaphragmatic mobility.

Conditions

Interventions

TypeNameDescription
DEVICEDB, VI and FITwo modalities of respiratory exercises based on deep and slow inspirations will be used: DB and IS. During DB, the researcher will place one hand slightly below the lower ribs in the abdominal region of the subject and the subject will be instructed to perform inspirations up to the maximum level of volume avoiding rib cage displacement; this recommendation will also be valid for exercises using incentive spirometers. IS will be executed using two different devices: Triflo II and Voldyne.

Timeline

Start date
2009-10-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2009-10-19
Last updated
2010-05-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00997737. Inclusion in this directory is not an endorsement.